Raffaella Gentilella
Raffaella Gentilella publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Metabolism, Diabetes, and Cancer.
- World rank
- #2,929,725 of 7,710,434 ranked researchers
- Rank in Italy
- #98,900 of 242,206
- Works
- 45
- Citations
- 1.2k
- Citations per work
- 27.2
What does Raffaella Gentilella research?
Raffaella Gentilella's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (12%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3066.3%
- Medicine3066.3%
- Everything else817.3%
- Life Sciences716.4%
- 1Endocrinology, Diabetes and Metabolism52% of their works
- 2Molecular Biology12% of their works
- 3Surgery7% of their works
- 4Endocrine and Autonomic Systems5% of their works
- 5Pharmacology5% of their works
- 6Geriatrics and Gerontology2% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Growth Hormone and Insulin-like Growth Factors
- Regulation of Appetite and Obesity
- Pharmacology and Obesity Treatment
- Bariatric Surgery and Outcomes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Which keywords describe Raffaella Gentilella's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Cardiovascular Outcomes, Glucose Control, Diabetes, Continuous Glucose Monitoring and Hypoglycemia.
- Hyperglycemia
- Metabolic Surgery
- Pharmacotherapy
- Ghrelin
- Insulin-like Growth Factors
- Weight Loss
- AMP-Activated Protein Kinase
- Hypoglycemia
- Diabetes
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- Type 2 Diabetes
- Glucose Control
- Continuous Glucose Monitoring
- Obesity
- Metformin
- IGF-1
- Anti-Obesity Drugs
- Leptin
- Bariatric Surgery
- Critical Care
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Glycemic Control533 topics
- Insulin Therapy533 topics
- Type 2 Diabetes332 topics
- Cardiovascular Outcomes281 topic
- Glucose Control281 topic
- Diabetes262 topics
- Continuous Glucose Monitoring211 topic
- Hypoglycemia211 topic
- Obesity173 topics
- AMP-Activated Protein Kinase131 topic
- Metformin131 topic
- Weight Loss112 topics
- IGF-181 topic
- Insulin-like Growth Factors81 topic
- Anti-Obesity Drugs61 topic
- Ghrelin61 topic
- Leptin61 topic
- Pharmacotherapy61 topic
- Bariatric Surgery51 topic
- Metabolic Surgery51 topic
- Critical Care41 topic
- Hyperglycemia41 topic
Where does Raffaella Gentilella work?
Raffaella Gentilella's main affiliation in the publication record is Eli Lilly (Italy), Italy.
How many publications and citations does Raffaella Gentilella have?
OpenAlex counts 45 works and 1,224 citations for Raffaella Gentilella, an h-index of 14, ranking #2,929,725 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Raffaella Gentilella. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.